Directors

Audit & Supervisory Board Members

Global Corporate Function

Business Unit

Our six business units are responsible for strategic planning and execution in the regions of our business operations.

 

Functional Unit

Our four functional units, Research & Development, Technology, Quality Assurance & Regulatory Affairs, and Clinical Safety & Pharmacovigilance, help formulate and execute global strategies in their specialties. Each unit determines areas to be expanded globally, guides strategic planning and execution, and improves the efficiency of business operations.

 

Internal Audit

*1 CStO: Chief Strategy Officer *2 CDXO: Chief Digital Transformation Officer *3 CHRO: Chief Human Resources Officer

Corporate Officers (Daiichi Sankyo Company, Limited)

Name	Responsibilities
Sunao Manabe	Representative Director, Executive Chairperson & CEO
Hiroyuki Okuzawa	Representative Director, President & COO
Shoji Hirashima	Representative Director, Senior Executive Officer, Head of Japan Business Unit
Masahiko Ohtsuki	Director, Senior Executive Officer, Head of Global DX, CDXO*1
Takashi Fukuoka	Director, Senior Executive Officer, Head of Global Corporate Strategy, CStO*2
Wataru Takasaki	Executive Officer, Head of R&D Division
Hiroto Kashiwase	Executive Officer, Head of Technology Supervisory Division & Head of Supply Chain Division
Koji Ogawa	Executive Officer, Head of Global Corporate Planning & Management, CFO
Takashi Matsumoto	Executive Officer, Head of Global HR, CHRO*3
Tomoji Hashiba	Corporate Officer, In charge of External Affairs
Naoto Tsukaguchi	Corporate Officer, Head of Global Leagal & IP, Head of Global Compliance & Risk, Vice President of Legal Affairs Department, General Counsel
Akio Sakurai	Corporate Officer, Head of Sales & Marketing Division, Japan Business Unit
Toshinori Agatsuma	Corporate Officer, Vice President of Research Function, R&D Division
Kiminori Nagao	Corporate Officer, Head of ASCA Business Division
Nobuo Murakami	Corporate Officer, Vice President of Corporate Strategy Department, Global Corporate Strategy
Hiroshi Masumoto	Corporate Officer, Vice President of Data Intelligence Department, Global DX
Shizuko Ueno	Corporate Officer, Head of Medical Affairs Division, Japan Business Unit
Akihiro Inoguchi	Corporate Officer, Vice President of Development Function, R&D Division
Toshi Kajiro	Corporate Officer, Head of Pharmaceutical Technology Division, Technology Supervisory Division
Hiroya Senda	Corporate Officer, Vice President of Sales Planning Department, Sales & Marketing Division, Japan Business Unit
Satoru Ogawa	Corporate Officer, Vice President of Secretariat Department
Atsushi Tsukamoto	Corporate Officer, Head of Therapeutic Area Strategies, Daiichi Sankyo, Inc.
Tetsuya Iwabuchi	Corporate Officer, In charge of Business Development
Koji Sato	Corporate Officer, Head of US Corporate Division, Head of Global CMC Management Oncology & DSI Pharmaceutical Technology, Daiichi Sankyo Inc.
Tetsuya Ohira	Corporate Officer, Vice Presindet of Corporate Planning Department, Global Corporate Planning & Management
Koichi Nonaka	Corporate Officer, Head of Biologics Division, Technology Supervisory Division
Hanako Saito	Corporate Officer, In charge of QARA*4 & CSPV*5
Kenji Shigeta	Corporate Officer, Vice President of Oncology Business Department, Global Corporate Strategy

*1 CDXO: Chief Digital Transformation Officer 
*2 CStO: Chief Strategy Officer
*3 CHRO: Chief Human Resources Officer 
*4 QARA: Quality Assurance & Regulatory Affairs
*5 CSPV: Clinical Safety & Pharmacovigilance